{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:59:17Z","timestamp":1760299157861},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/jidsymp.2015.6","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T12:49:45Z","timestamp":1434545385000},"page":"29-31","source":"Crossref","is-referenced-by-count":10,"title":["Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans"],"prefix":"10.1016","volume":"17","author":[{"given":"Fangping","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-an","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjie","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinfen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghe","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jidsymp.2015.6_bb0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/jdv.12130","article-title":"Comparison of cytokine gene polymorphism in drug-induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"28","author":"Barbaud","year":"2014","journal-title":"J Eur Acad"},{"key":"10.1038\/jidsymp.2015.6_bb0015","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/pgs.12.89","article-title":"HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese","volume":"13","author":"Cao","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1038\/jidsymp.2015.6_bb0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens\u2013Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1038\/jidsymp.2015.6_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/rheumatology\/29.3.201","article-title":"Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study","volume":"29","author":"Donovan","year":"1990","journal-title":"Br J Rheumatol"},{"key":"10.1038\/jidsymp.2015.6_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jidsymp.2015.6_bb0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2230.2010.03922.x","article-title":"Cutaneous adverse drug reactions in a hospital-based Chinese population","volume":"36","author":"Huang","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1038\/jidsymp.2015.6_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/17410541.2.3.225","article-title":"HLA-B genotyping to detect carbamazepine- induced Stevens-Johnson syndrome: implications for personalized medicine","volume":"2","author":"Hung","year":"2005","journal-title":"Personalized Med"},{"key":"10.1038\/jidsymp.2015.6_bb0045","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1038\/jidsymp.2015.6_bb0050","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pgs.10.54","article-title":"HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"11","author":"Kim","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1038\/jidsymp.2015.6_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1038\/jidsymp.2015.6_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for Stevens-Johnson syndrome: ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1038\/jidsymp.2015.6_bb0065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1038\/jidsymp.2015.6_bb0070","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1038\/jidsymp.2015.6_bb0075","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/j.1600-6143.2009.02788.x","article-title":"Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver trans- plantation","volume":"9","author":"Mennicke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/jidsymp.2015.6_bb0080","first-page":"2241","article-title":"Association of HLA type with Stevens\u2013Johnson syndrome induced by methazolamide treatment","volume":"41","author":"Moon","year":"2000","journal-title":"J Korean Ophthalmol Soc"},{"key":"10.1038\/jidsymp.2015.6_bb0085","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0140-6736(98)08513-4","article-title":"Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group","volume":"353","author":"Mottonen","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/jidsymp.2015.6_bb0090","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jidsymp.2015.6_bb0095","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/jidsymp.2015.6_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"10.1038\/jidsymp.2015.6_bb0105","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.1365-2222.1998.00419.x","article-title":"T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction","volume":"28","author":"Schnyder","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1038\/jidsymp.2015.6_bb0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/ACI.0b013e32833b1eb3","article-title":"Genetic and ethnic risk factors associated with drug hypersensitivity","volume":"10","author":"Kim","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1038\/jidsymp.2015.6_bb0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.7547\/0980479","article-title":"Penicillin and cephalosporin drug allergies: a paradigm shift","volume":"98","author":"Smith","year":"2008","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1038\/jidsymp.2015.6_bb0120","first-page":"561","article-title":"Two cases of HLA-B59(+) Stevens\u2013Johnson syndrome (SJS)\u2013toxic epidermal necrolysis (TEN) associated with methazolamide treatment","volume":"43","author":"Sung","year":"2005","journal-title":"Korean Dermatol"},{"key":"10.1038\/jidsymp.2015.6_bb0125","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":"Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"key":"10.1038\/jidsymp.2015.6_bb0130","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Clinical practice","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"Gout N Engl J Med"},{"key":"10.1038\/jidsymp.2015.6_bb0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.22.5.404","article-title":"Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study","volume":"22","author":"Van Hees","year":"1981","journal-title":"Gut"},{"key":"10.1038\/jidsymp.2015.6_bb0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.mcna.2010.04.003","article-title":"Drug hypersensitivity reactions: pathomechanism and clinical symptoms","volume":"94","author":"Pichler","year":"2010","journal-title":"Med Clin N Am"},{"key":"10.1038\/jidsymp.2015.6_bb0145","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Wolkenstein","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1038\/jidsymp.2015.6_bb0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00002281-200205000-00015","article-title":"Gout and hyperuricemia","volume":"14","author":"Wortmann","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1038\/jidsymp.2015.6_bb0155","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2217\/pgs.14.69","article-title":"HLA-B*13:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population","volume":"15","author":"Yang","year":"2014","journal-title":"Pharmacogenomics"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087002416300235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087002416300235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:45:20Z","timestamp":1566866720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087002416300235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1087002416300235"],"URL":"https:\/\/doi.org\/10.1038\/jidsymp.2015.6","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}